AI in Action: Redefining Drug Discovery
7 minutes

AI in Action: Redefining Drug Discovery

Primary Analyst: Madhav Pitaliya, Analyst
Contributors
Primary Analyst: Madhav Pitaliya, Analyst
Sector Lead: Anand Kumar, Associate Director of Retail Research
Insight Report

What's Inside

Artificial intelligence (AI) and generative AI are transforming industries worldwide, and the healthcare sector is no exception. Discover the applications and benefits of AI in revolutionizing drug discovery, and notable technology providers in the space.

Companies mentioned in this report include: BenevolentAI, Exscientia, Insilico Medicine, Novo Nordisk, Pfizer, XtalPi

Other relevant research:

You are currently viewing a preview of this report.

Please select an access option to view the full report. Hide Options -

Get unlimited access to all our research with one of our subscription plans.

View Subscription Plans
or

Contact us to purchase this report.

Contact us